文献速递乳腺癌放疗放疗物理与技术

体外照射的肿瘤疫苗在同系小鼠乳腺癌模型中增强放疗与PD-L1阻断的抗肿瘤疗效

In vitro-irradiated cancer vaccine enhances anti-tumor efficacy of radiotherapy and PD-L1 blockade in a syngeneic murine breast cancer model.
PubMed 文献 · Radiother Oncol · 2024-08-17

本研究在同系小鼠乳腺癌模型中测试体外照射肿瘤细胞疫苗(ICV),将不同剂量照射杀死的肿瘤细胞及其上清静脉注射,联合局部放疗(24 Gy分三次)与PD-L1阻断。ICV显著增加脾CD8+ T细胞的效应记忆表型和干扰素-γ产生能力,三联疗法显著延缓照射及未照射肿瘤生长,并增加肿瘤微环境中CD8+ T细胞及效应记忆CD8+ T细胞比例、降低CTLA-4+耗竭CD8+ T细胞比例,同时显著提高血浆干扰素-γ水平及脾和肿瘤引流淋巴结中效应T细胞增殖。

要点

  • ICV联合局部放疗与PD-L1阻断显著延缓照射及未照射肿瘤生长。
  • 三联疗法增加肿瘤微环境CD8+ T细胞和效应记忆CD8+ T细胞比例。
  • 三联疗法降低肿瘤微环境CTLA-4+耗竭CD8+ T细胞比例。

核心结论

  • ICV通过增强抗肿瘤免疫应答提高了局部放疗与PD-L1阻断的疗效。
  • 作者认为体外照射肿瘤细胞产物具有治疗潜力。

研究设计与样本

  • 在同系小鼠乳腺癌模型中测试体外照射肿瘤细胞疫苗(ICV),将不同剂量照射杀死的肿瘤细胞及其上清静脉注射。
  • 评估局部放疗(24 Gy分三次)、PD-L1阻断与ICV联合方案。
  • 通过流式细胞术和免疫组化分析免疫细胞谱,用多重免疫分析检测细胞因子水平。

主要发现

  • ICV显著增加脾CD8+ T细胞的效应记忆表型和干扰素-γ产生能力。
  • 体外照射产物含有免疫应答相关分子。
  • ICV联合局部放疗与PD-L1阻断显著延缓照射及未照射肿瘤的生长。
  • 三联疗法增加肿瘤微环境中CD8+ T细胞和效应记忆CD8+ T细胞比例,降低CTLA-4+耗竭CD8+ T细胞比例。
  • 三联疗法显著增加血浆干扰素-γ水平及脾和肿瘤引流淋巴结中效应T细胞增殖。

关键数值与推荐

  • 局部放疗剂量为24 Gy分三次。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Local radiotherapy (RT) exerts immunostimulatory effects by inducing immunogenic cell death. However, it remains unknown whether in vitro-irradiated tumor cells can elicit anti-tumor responses and enhance the efficacy of local RT and immune checkpoint inhibitors when injected in vivo. METHODS AND MATERIALS: We tested the "in vitro-irradiated cancer vaccine (ICV)", wherein tumor cells killed by varying doses of irradiation and their supernatants are intravenously injected. We examined the efficacy of combining local RT (24 Gy in three fractions), PD-L1 blockade, and the ICV in a murine breast cancer model. The immune cell profiles were analyzed via flow cytometry and immunohistochemistry. The cytokine levels were measured by multiplex immunoassays. RESULTS: The ICV significantly increased the effector memory phenotype and interferon-γ production capacity in splenic CD8+ T cells. The in vitro-irradiated products contained immune response-related molecules. When combined with local RT and PD-L1 blockade, the ICV significantly delayed the growth of irradiated and non-irradiated tumors. The triple combination therapy increased the proportions of CD8+ T cells and effector memory CD8+ T cells while decreasing the proportion of CTLA-4+ exhausted CD8+ T cells within tumor microenvironment. Additionally, plasma level of interferon-γ and proliferation of effector T cells in the spleen and tumor-draining lymph nodes were significantly increased by the triple combination therapy. CONCLUSIONS: The ICV enhanced the therapeutic efficacy of local RT and PD-L1 blockade by augmenting anti-tumor immune responses. Our findings suggest a therapeutic potential of in vitro-irradiation products of tumor cells.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Kim Y, Jeon SH, Kim S, et al. In vitro-irradiated cancer vaccine enhances anti-tumor efficacy of radiotherapy and PD-L1 blockade in a syngeneic murine breast cancer model. Radiother Oncol. 2024. PMID: 39159681. doi:10.1016/j.radonc.2024.110480

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。